Latest news with #MubadalaInvestmentCompanyPJSC
Al Etihad
20-05-2025
- Automotive
- Al Etihad
Sanad, Etihad strengthen aviation supply chain with Trent 700 engine transaction
20 May 2025 16:37 ABU DHABI (WAM) Sanad, the global aerospace engineering and leasing solutions leader, wholly owned by Abu Dhabi's sovereign investor Mubadala Investment Company PJSC (Mubadala), has announced the acquisition of Rolls Royce Trent 700 engines from Etihad Airways (EY), the national airline of the United Arab agreement was signed by Kashish Kohli, Group Chief Financial Officer of Sanad, and Captain Majed Al Marzouqi, Interim Chief Operations and Guest Officer, during the third edition of the Make it in the Emirates Forum, underscoring both companies' alignment with the UAE's national industrial strategy and long-term vision for localised aerospace capabilitiesThis strategic acquisition marks a major milestone in Sanad's efforts to expand its global engine asset management and MRO capabilities. It also reinforces the UAE's ambition to establish a globally competitive aviation supply chain acquiring these engines, Sanad expands its ability to support airlines worldwide with cost-effective spare parts and flexible leasing solutions, enhancing turnaround times, reducing maintenance costs, and boosting operational efficiency across its global customer deal comes at a pivotal moment for the aviation industry. As operators continue to prioritise efficiency and fleet longevity amid persistent supply chain disruptions and delays in new aircraft deliveries, platforms like the Rolls-Royce Trent 700 remain in high designed for the Airbus A330, the Trent 700 has achieved a 60 percent market share, over 2,000 units delivered to date, and more than 60 million flight hours logged. Its proven efficiency and reliability make it a key platform for Sanad to deliver sustainable lifecycle solutions and long-term value to operators Janahi, Managing Director and Group CEO, highlighted the significance of the transaction, saying, 'This acquisition represents a strategic step forward in our two-decade partnership with Etihad, enabling us to expand our capabilities and meet the evolving needs of the regional and global aviation markets. As the only independent MRO provider in the world with a long-term strategic partnership with Rolls-Royce for the Trent 700, Sanad currently services 25% of the global Trent 700 fleet."This acquisition not only deepens that capability, it reinforces Abu Dhabi's role as a global center for aerospace innovation and sustainable industrial growth. Our partnership with Etihad Airways continues to drive tangible value, demonstrating how collaboration between UAE national champions.'Antonoaldo Neves, Etihad Airways Chief Executive Officer, commented, 'This is a mutually beneficial agreement that reflects our commitment to optimising our fleet as we phased out the A330ceo. It supports a trusted UAE partner and contributes to the growth of the local aerospace sector.'Beyond meeting immediate market demand, this acquisition plays a critical role in advancing the UAE's national strategy to localise aerospace capabilities, accelerate sustainable economic growth, and position Abu Dhabi as a leading global aviation supply chain hub. By expanding its service portfolio, Sanad is driving international investment, cultivating local talent, and delivering world-class MRO and leasing solutions from Abu Dhabi to the global aviation market.
Mid East Info
19-05-2025
- Business
- Mid East Info
Mubadala Launches its Latest National Champion – 'Mubadala Bio' to Transform Life Sciences in the UAE and Beyond
With a focus on enabling local manufacturing and distribution of therapies, Mubadala Bio is reinforcing national drug security and positioning Abu Dhabi as a regional hub for life sciences Abu Dhabi, May 2025 – Mubadala Investment Company PJSC (Mubadala), an Abu Dhabi sovereign investor, today announced the launch of Mubadala Bio, a life sciences company committed to strengthening the life sciences sector in the UAE and advancing better health outcomes for the UAE and the world. The launch of this National Champion represents a strategic step that reflects Mubadala's commitment to healthcare resilience, strengthening drug security, expanding access to essential, high-quality therapeutics and medical devices, and accelerating the UAE's economic diversification and building a knowledge-based economy. Mubadala Bio's integrated portfolio includes 10 facilities spans across Asia, Africa and Europe (with 6 located within the Emirates), serving over 100 countries. Across these sites, the cumulative manufacturing capacity of its facilities exceeds 2.5 billion tablets and capsules, 120 million IVs and injectables annually, and spans 110,000 square meters – enabling the production and global distribution of more than 10,000 products. Mubadala Bio's portfolio focuses on key therapy areas that address some of the world's most pressing health needs, supporting the full continuum of care, from prevention and diagnosis to treatment, ongoing support, and complementary medicine. By forging long-term strategic partnerships with global industry leaders and top-tier academic institutions, Mubadala Bio is accelerating biopharma innovation and local manufacturing, cultivating world-class talent and driving accelerated advancements. This holistic strategy spans the full continuum of care by providing integrated disease solutions across prevention, diagnostics, treatment, supportive treatment, and complementary medicine. Dr. Bakheet Al Katheeri, Chief Executive Officer of Mubadala's UAE Investments Platform, said: 'By launching Mubadala Bio, we are taking a transformative step towards strengthening national drug security and fostering innovation in life sciences. This positions Mubadala at the forefront of the industry, enabling us to drive long-term economic growth, build a resilient life sciences ecosystem, and elevate Abu Dhabi's role in delivering impactful health solutions on a global scale. Through our National Champions, we continue our efforts to accelerate the UAE's economic diversification by investing in priority sectors and support building a knowledge-based economy. Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala's UAE Investments Platform, added: 'With the launch of Mubadala Bio, we are proud to take a significant step forward in supporting the UAE's ambition to be a global leader in the life sciences industry. By focusing on local manufacturing and enhancing our distribution and logistics capabilities, we are building a more resilient and self-sustaining life sciences sector, one that responds to today's needs while preparing for tomorrow's challenges.' Focusing on integrated biopharma and pharma logistics, Mubadala Bio aims to support the UAE's Centennial 2071 vision. As part of its launch, it will mark its first physical presence at Make it in the Emirates 2025, showcasing the UAE's success in building a competitive life sciences industry and reinforcing its position as a hub for innovation and local manufacturing. About Mubadala: Mubadala Investment Company is a sovereign investor managing a global portfolio, aimed at generating sustainable financial returns for the Government of Abu Dhabi. Mubadala's US$330 billion (AED 1,212 billion) portfolio spans six continents with interests in multiple sectors and asset classes. We leverage our deep sectoral expertise and long-standing partnerships to drive sustainable growth and profit, while supporting the continued diversification and global integration of the economy of the United Arab Emirates. About Mubadala Bio: Mubadala Bio, a wholly owned subsidiary of Mubadala Investment Company, launched in 2025, is a life sciences company dedicated to pursuing better health outcomes for the UAE and beyond. With a growing presence across the UAE, Asia, Africa, and Europe, Mubadala Bio is advancing drug security, improving access to essential therapeutics, and accelerating the development of a sustainable life sciences sector, aligned with the UAE's vision for a knowledge-based economy. Operating across two core verticals — Integrated Biopharma and Pharma Logistics — Mubadala Bio focuses on local manufacturing and distribution to ensure the availability of the most critical and in-demand medical therapies. Mubadala Bio focuses on some of the world's most pressing therapy areas, supporting the full continuum of care. Mubadala Bio is committed to affordability, global partnerships, and investing in national talent to help shape the future of healthcare locally and worldwide.
Web Release
19-05-2025
- Business
- Web Release
Mubadala Launches its Latest National Champion – 'Mubadala Bio' to Transform Life Sciences in the UAE and Beyond
Mubadala Investment Company PJSC (Mubadala), an Abu Dhabi sovereign investor, today announced the launch of Mubadala Bio, a life sciences company committed to strengthening the life sciences sector in the UAE and advancing better health outcomes for the UAE and the world. The launch of this National Champion represents a strategic step that reflects Mubadala's commitment to healthcare resilience, strengthening drug security, expanding access to essential, high-quality therapeutics and medical devices, and accelerating the UAE's economic diversification and building a knowledge-based economy. Mubadala Bio's integrated portfolio includes 10 facilities spans across Asia, Africa and Europe (with 6 located within the Emirates), serving over 100 countries. Across these sites, the cumulative manufacturing capacity of its facilities exceeds 2.5 billion tablets and capsules, 120 million IVs and injectables annually, and spans 110,000 square meters – enabling the production and global distribution of more than 10,000 products. Mubadala Bio's portfolio focuses on key therapy areas that address some of the world's most pressing health needs, supporting the full continuum of care, from prevention and diagnosis to treatment, ongoing support, and complementary medicine. By forging long-term strategic partnerships with global industry leaders and top-tier academic institutions, Mubadala Bio is accelerating biopharma innovation and local manufacturing, cultivating world-class talent and driving accelerated advancements. This holistic strategy spans the full continuum of care by providing integrated disease solutions across prevention, diagnostics, treatment, supportive treatment, and complementary medicine. Dr. Bakheet Al Katheeri, Chief Executive Officer of Mubadala's UAE Investments Platform, said: 'By launching Mubadala Bio, we are taking a transformative step towards strengthening national drug security and fostering innovation in life sciences. This positions Mubadala at the forefront of the industry, enabling us to drive long-term economic growth, build a resilient life sciences ecosystem, and elevate Abu Dhabi's role in delivering impactful health solutions on a global scale. Through our National Champions, we continue our efforts to accelerate the UAE's economic diversification by investing in priority sectors and support building a knowledge-based economy. Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala's UAE Investments Platform, added: 'With the launch of Mubadala Bio, we are proud to take a significant step forward in supporting the UAE's ambition to be a global leader in the life sciences industry. By focusing on local manufacturing and enhancing our distribution and logistics capabilities, we are building a more resilient and self-sustaining life sciences sector, one that responds to today's needs while preparing for tomorrow's challenges.' Focusing on integrated biopharma and pharma logistics, Mubadala Bio aims to support the UAE's Centennial 2071 vision. As part of its launch, it will mark its first physical presence at Make it in the Emirates 2025, showcasing the UAE's success in building a competitive life sciences industry and reinforcing its position as a hub for innovation and local manufacturing. For more information about Mubadala Bio and its initiatives, please visit
Gulf Today
08-05-2025
- Business
- Gulf Today
26 teams in fray as second edition of Oasis Cup to begin on Friday in Abu Dhabi
The Oasis Flag Football Cup, the largest and most anticipated flag football tournament in the region, is officially returning from May 9–11 at Active Al Maryah Island, Abu Dhabi. Building on the success of its inaugural edition, the 2025 tournament continues to grow in scale and reputation, uniting top-tier teams and fans for an electrifying celebration of sport, community, and competition. This year's Oasis Cup will welcome 26 elite teams from across the UAE and beyond, more than triple last year's participation, representing eight countries in a high-energy, three-day tournament. As flag football gains global traction ahead of its Olympic debut at Los Angeles 2028, the Oasis Cup reinforces Abu Dhabi's position as a driving force in the sport's regional rise. With a dynamic line-up of fast-paced matches, the tournament showcases the expanding reach and growing popularity of flag football in the region. The Oasis Flag Football Cup is proudly presented by Sanad, the global aerospace engineering and leasing solutions leader, wholly owned by Abu Dhabi's sovereign investor Mubadala Investment Company PJSC (Mubadala). Sanad's continued support for sports development and active community engagement reflects its broader mission to foster health, wellness, and community engagement through sports. 'Sanad is proud to support the Oasis Flag Football Cup 2025, a vibrant platform that unites athletes and fans from across the region, through the spirit of competition and sportsmanship,' said Mansoor Janahi, Managing Director and Group CEO of Sanad. 'Through this partnership, we continue to champion the UAE's vision of promoting active lifestyles and inclusive sports participation. The Oasis Cup goes beyond the field—it is a celebration of community, unity, and the transformative power of sport.' 'Our vision with the Oasis Flag Football Cup is to create more than just a tournament—we're building a community,' said Basma Abu Al Nasr, Acting CEO of Abu Dhabi Entertainment Company. 'We're proud to see this event become a hub for talent, unity, and high-level competition. As organizers, it's incredibly rewarding to witness how the Oasis Flag Football Cup brings communities together and shines a spotlight on the UAE's leadership in developing emerging sports.' The event is open to the public and promises an engaging experience for all ages, with exciting matches, fan zones, and a festive atmosphere that embodies the spirit of modern sport. Whether you're a long-time flag football enthusiast or a newcomer to the game, Oasis Cup 2025 is a must-attend event on the UAE's sports calendar. Last year, taking home the championship trophy was Kuwaiti team Al Qadsia, handily toppling Egypt's Pharaohs 41 – 12 in a high-energy battle. UAE Eagles earned a third place finish by defeating a worthy opponent, Saudi Arabia-based Al-Bahara.
Al Etihad
18-03-2025
- Automotive
- Al Etihad
Sanad achieves strong results, surpassing Dh4.92 billion in revenues for 2024, marking a 40% surge
Abu Dhabi (Aletihad) Sanad, the global aerospace engineering and leasing solutions leader wholly owned by Abu Dhabi's sovereign investor Mubadala Investment Company PJSC (Mubadala), has announced exceptional financial results for 2024, surpassing the $1 billion milestone for the first time in its history. The company reported Dh4.92 billion ($1.34 billion) in revenue, a 40% increase from Dh3.4 billion ($925 million) in 2023, underscoring its rapid expansion and strategic market positioning. Sanad's exceptional performance was fueled by unprecedented global demand for engine MRO services, expansion into key global markets, and transformative strategic agreements with leading airlines and global Original Engine Manufacturers (OEM). Sanad's Leasing division witnessed significant achievements, executing five major transactions exceeding Dh1.8 billion ($490 million) in combined value, positioning the division to develop its new long-term growth strategy. The company's Dh33 billion order book was bolstered by major partnerships with Air Mauritius, Deucalion Aviation, Asiana Airlines, and Lion Air, propelling its contracted business by an additional Dh4 billion in 2024. Additionally, Sanad's global expansion strategy was reinforced by establishing a dedicated sales presence in Singapore, further strengthening its footprint in the high-growth APAC region and enhancing its global sales network. Amer Siddiqui, Group Chairman of Sanad, stated, 'Sanad's record-breaking performance in 2024 is a testament to our resilient strategy, operational excellence, and long-term investment plans. This achievement reinforces our pivotal role in Abu Dhabi's vision of becoming a global aviation hub which solidifies Sanad's position as a leader in the global aviation market. Our continued growth underscores the strength of our business model and our unwavering commitment to delivering world-class solutions to our partners from our home base in Abu Dhabi.' Mansoor Janahi, Managing Director and Group CEO of Sanad, said, '2024 was a transformational year for Sanad. Surpassing $1.34 billion in revenue reflects the strong market demand for our services, our advanced engine MRO and leasing capabilities, and the dedication of our exceptional teams. With strategic expansions, new partnerships, and an unwavering focus on innovation and service-delivery, we are well-positioned to sustain this momentum and drive the future of the aerospace sector in Abu Dhabi.' Scaling MRO Capabilities to Meet Unprecedented Demand Sanad further solidified its position as a leading independent engine MRO service provider, recording 161 engine inductions, a 29% increase from 2023. This surge was fueled by soaring demand for Trent 700, V2500, and LEAP engine maintenance. To accommodate this demand, Sanad invested over Dh100 million to expand its MRO infrastructure, ensuring state-of-the-art engine repair and maintenance capabilities. As part of its continued growth, Sanad marked the first anniversary of its LEAP Engine MRO Center which was inaugurated in 2023, expanding its expertise to include both LEAP-1A and LEAP-1B capabilities. This milestone reinforces Sanad's commitment to capability development and service excellence in the global aviation industry. To strengthen its market presence, Sanad has also established a dedicated sales presence in Singapore, complementing its existing sales teams in Europe and the Middle East. This expansion reinforces its global sales network and positions the company closer to key customers in the high-growth APAC region. In 2024, Sanad's MRO division processed 54 V2500 engines, 40 Trent 700 engines, 28 GEnx engines, and 21 LEAP engines, performing over 43,000-part inspections and 19,000 in-house repairs. Additionally, Sanad welcomed seven new customers in 2024, bringing its total customer base to over 40, including leading airlines and OEMs worldwide. This expansion of capacity and capabilities, combined with growing global air travel, positions Sanad as a preferred partner for airlines and OEMs worldwide. Driving Financial Strength Through Strategic Asset Monetization Sanad's Leasing division played a pivotal role in revenue growth executing a total of five strategic deals, with a combined capital value exceeding Dh1.8 billion. These deals underscored Sanad's ability to optimize its asset portfolio and enhance financial strength through strategic monetizations. Among the division's standout achievements was the sale of 16 engines to Etihad Airways, valued at nearly Dh1.5 billion. Additionally, high-value CFM56 engine transactions with CFM Materials and component sales to AerSale, further bolstered Sanad's financial position, demonstrating its ability to extract maximum value from its leasing assets. Sanad also completed the sale of a GE90 engine and key component transactions with AerCap, executed the sale of two CFM56-7B26 engines to CFM Materials. These strategic asset monetization efforts further enhanced Sanad's financial position and supported its long-term growth strategy. Human Capital Investments: Strengthening the Future Workforce Sanad's workforce saw a 20% expansion in 2024, with over 130 new hires joining the company. Emiratization remained a core focus, with UAE Nationals now comprising 32% of the workforce, a 19% increase from 2023. The company accelerated talent development through apprenticeship programs and leadership initiatives, investing in over 3,109 training hours in upskilling programs. Strategic collaborations with global OEMs such as Rolls-Royce and leading academic institutions, including Embry-Riddle Aeronautical University and Khalifa University further underscore Sanad's commitment to developing the next generation of aerospace leaders. These programs span multiple levels, covering technical training, leadership development, and specialized upskilling initiatives to ensure a highly capable and future-ready workforce. Commitment to Quality and Safety Sanad continued to uphold the highest safety and quality standards, securing a new certification from the European Aviation Safety Agency (EASA) and implementing an advanced Safety Management System (SMS). The company's compliance with 23+ global aviation authorities, including EASA, FAA, and the Chinese aviation authority, reaffirms its commitment to regulatory excellence and global operational reliability. Looking Ahead: Innovation and Expansion Sanad is strategically poised for further global expansion, with plans to increase engine MRO capacity within the UAE while targeting global growth in emerging markets in Africa, India, and Southeast Asia. The company is strengthening its human capital development, forging strategic industry collaborations, and continues to invest in cutting-edge MRO solutions, automation, and AI-driven initiatives to drive efficiency and innovation. Strengthening its global partnerships remains a priority as Sanad reinforces its leadership role in the aviation industry. Looking ahead, Sanad remains focused on delivering long-term stakeholder value, driving industry innovation, and further establishing Abu Dhabi as a global aviation hub.
